- To develop a translational research program that characterizes host-parasite interactions responsible for major global health threats such as malaria and HIV; in particular to determine the molecular basis for adverse outcomes in malaria and to translate this knowledge into novel therapeutic interventions.
- To elucidate of the molecular mechanisms of antimalarial drug resistance and develop new therapies to reverse drug resistance.
- To develop molecular diagnostic and epidemiologic tools for the detection and surveillance of emerging diseases, especially those that threaten travelers, migrants, blood safety, and global health and security.
- Travel Medicine: studies examining the risk of acquisition of emerging and resurging infectious diseases, especially those relevant to travel and migration.
- Global Health and equity, knowledge sharing and education: including the transfer of appropriate technologies and the training of research scientists in the developing world, enabling and empowering them to address their own problems in a sustainable fashion.
Anemia and transfusion requirements among Ugandan children with severe malaria treated with intravenous artesunate.
Pediatr Hematol Oncol. 2019 Dec 12;:1-13
Vitamin D Concentration during Early Pregnancy and Adverse Outcomes among HIV-Negative Women in Dar-es-Salaam, Tanzania: A Case-Control Study.
Nutrients. 2019 Dec 02;11(12):
New insights into microvascular injury to inform enhanced diagnostics and therapeutics for severe malaria.
Virulence. 2019 Dec;10(1):1034-1046
Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
PLoS Med. 2019 Oct;16(10):e1002914
Cutaneous and Mucocutaneous Leishmaniasis in Travelers and Migrants: A 20-year GeoSentinel Surveillance Network Analysis.
J Travel Med. 2019 Jul 30;:
Front Microbiol. 2019;10:1924
Erratum for Bansal et al., "Rectal and Naris Swabs: Practical and Informative Samples for Analyzing the Microbiota of Critically Ill Patients".
mSphere. 2018 May-Jun;3(3):
Prognostic accuracy of sTREM-1-based algorithms in febrile adults presenting to Tanzanian outpatient clinics.
Clin Infect Dis. 2019 May 18;:
Fever in returning travellers and migrants: disease severity markers to improve triage and management.
J Travel Med. 2019 May 16;:
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Canada Research Chair in Molecular Parasitology
Director, Sandra A. Rotman Laboratories, Sandra Rotman Centre for Global Health
Science Director, Tropical Disease Unit, University Health Network - Toronto General Hospital
Professor of Medicine, University of Toronto
Professor, Lab Medicine and Pathobiology, University of Toronto
Professor, Institute of Medical Sciences, University of Toronto